Lectures from the USHER Syndrome Symposium 2018 - now online!
From 19 - 21 July 2018 the International Usher-Syndrome-Symposium took place in Mainz with great success. The presentations of the Patient Symposium are now available online as video recordings and transcripts.
Patients, scientists and doctors from many countries took part to discuss progress in the development of therapies for patients. There is currently no approved therapy for Usher syndrome, but a number of therapy options have been presented and discussed which are in development and at clinical trial stage.
Usher syndrome is the most common cause of hereditary deaf blindness, affecting approximately 400,000 people worldwide. Children with Usher syndrome are born either deaf or with hearing impairment facing progressive hearing loss, in some cases accompanied by balance disorders. Already in childhood or teenage years, vision loss manifests in the form of so-called retinitis pigmentosa (also known as retinopathia pigmentosa, RP). Most people with Usher syndrome are classified as blind in adulthood. Today, retinal implants are available for people who are blind by RP.
The enabling conditions for this , yet to be created, were also discussed at the symposium in a direct exchange between those affected and the manufacturer.
In particular, we would like to draw your attention to Prof. Dr. E. Zrenner's lecture on implants and electrostimulation.
You can also listen to the informative lecture by Dr. Alfred Stett on retinal implants "Subretinal Implant Alpha AMS - Current Development and Successes".
You can find all lectures under International Symposium on Usher Syndrome.